Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mosaic ImmunoEngineering Inc. (CPMV : OTC)

• Company Description    Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly known as Patriot Scientific Corporation, is based in NOVATO, CA. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $1.20 Daily Weekly Monthly 20 Day Moving Average: 642 shares Shares Outstanding: 7.23 (millions) Market Capitalization: $8.67 (millions) Beta: 1.52 52 Week High: $3.00 52 Week Low: $0.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 66.53% 87.54% 12 Week 71.43% 88.45% Year To Date 17.65% 43.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1537 SOUTH NOVATO BOULEVARD SUIT 5 - NOVATO,CA 94947 USA ph: 657-208-0890 fax: 760-547-2705 info@mosaicie.com http://www.mosaicie.com

• General Corporate Information    Officers Steven King - President and Chief Executive Officer; Director Paul Lytle - EVP; Chief Financial Officer; Director Nicole Steinmetz - Acting Chief Scientific Officer; Director Robert Baffi - Director Gloria Felcyn - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 61945M101 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/02/22 Share - Related Items Shares Outstanding: 7.23 Most Recent Split Date: 12.00 (0.00:1) Beta: 1.52 Market Capitalization: $8.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/02/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 26.67% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - -846.02 12/31/21 - -929.72 09/30/21 - -741.72 Current Ratio 03/31/22 - 0.15 12/31/21 - 0.12 09/30/21 - 0.23 Quick Ratio 03/31/22 - 0.15 12/31/21 - 0.12 09/30/21 - 0.23 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - -0.47 12/31/21 - -0.39 09/30/21 - -0.30 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©